Concepedia

Xiling Yuan

XY

Statistics

Publications

13

Citations

1.6K

H-Index

12

Active since

1998

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Bristol-Myers Squibb (United States)

University of Ottawa

Xiling Yuan is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in life sciences, molecular biology, and microbiology.

ORCID

Publications per year

1998–2024

13

Publications

13

Complete genome sequence of an M1 strain of <i>Streptococcus pyogenes</i>

Joseph J. Ferretti, W. Michael McShan, Dragana Ajdić et al. · Proceedings of the National Academy of Sciences · 2001 · 942 citations · Full text

, , +17

Adipose Fibroblast Growth Factor 21 Is Up-Regulated by Peroxisome Proliferator-Activated Receptor γ and Altered Metabolic States

Eric S. Muise, B. Azzolina, David W. Kuo et al. · Molecular Pharmacology · 2008 · 298 citations

, , +17

A Glucan Synthase <i>FKS1</i> Homolog in <i>Cryptococcus neoformans</i> Is Single Copy and Encodes an Essential Function

John R. Thompson, Cameron Douglas, Weili Li et al. · Journal of Bacteriology · 1999 · 196 citations · Full text

, , +17

Structure-activity relationships of biphenyl tetrazoles as metallo-β-lactamase inhibitors

Jeffrey H. Toney, Kelly A. Cleary, Gail G. Hammond et al. · Bioorganic & Medicinal Chemistry Letters · 1999 · 52 citations · Full text

, , +16

The Clinical Development of Taldefgrobep Alfa: An Anti-Myostatin Adnectin for the Treatment of Duchenne Muscular Dystrophy

Francesco Muntoni, Barry J. Byrne, Hugh J. McMillan et al. · Neurology and Therapy · 2024 · 23 citations · Full text

, , +14

1–5 of 13